Cargando…
Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/Axl-induced epithelial-mesenchymal transition
Qigesan (QGS) has been used to effectively treat esophageal cancer (EC) for decades in China, but the mechanism by which it suppresses EC metastasis remains unknown. In this study, we examined the effects of QGS on EC cell mobility. Using immunohistochemistry and immunofluorescence, expression of Ga...
Autores principales: | Kong, Lingyu, Lu, Xin, Chen, Xuanyu, Wu, Yunyan, Zhang, Yushuang, Shi, Huijuan, Li, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288918/ https://www.ncbi.nlm.nih.gov/pubmed/32432570 http://dx.doi.org/10.18632/aging.103238 |
Ejemplares similares
-
Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression
por: Kong, Lingyu, et al.
Publicado: (2019) -
Ursolic Acid Inhibits Epithelial-Mesenchymal Transition through the Axl/NF-κB Pathway in Gastric Cancer Cells
por: Li, Jinxia, et al.
Publicado: (2019) -
Novel AXL-specific inhibitor ameliorates kidney dysfunction through the inhibition of epithelial-to-mesenchymal transition of renal tubular cells
por: Kurata, Atsuo, et al.
Publicado: (2020) -
FRK inhibits breast cancer cell migration and invasion by suppressing epithelial-mesenchymal transition
por: Ogunbolude, Yetunde, et al.
Publicado: (2017) -
Pharmaceutical inhibition of AXL suppresses tumor growth and invasion of esophageal squamous cell carcinoma
por: Han, Sha, et al.
Publicado: (2020)